Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 274

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

DNA-Encoded Library Screening Identifies Benzo[b][1,4]oxazepin-4-ones as Highly Potent and Monoselective Receptor Interacting Protein 1 Kinase Inhibitors

Open access
Harris, Philip A., King, Bryan W., Bandyopadhyay, Deepak, Berger, Scott B., Campobasso, Nino, Capriotti, Carol A., Cox, Julie A., Dare, Lauren, Dong, Xiaoyang, Finger, Joshua N., Grady, LaShadric C., Hoffman, Sandra J., Jeong, Jae U., Kang, James, Kasparcova, Viera, Lakdawala, Ami S., Lehr, Ruth, McNulty, Dean E., Nagilla, Rakesh, Ouellette, Michael T., Pao, Christina S., Rendina, Alan R., Schaeffer, Michelle C., Summerfield, Jennifer D., Swift, Barbara A., Totoritis, Rachel D., Ward, Paris, Zhang, Aming, Zhang, Daohua, Marquis, Robert W., Bertin, John, Gough, Peter J.·2016·Journal of Medicinal Chemistry

Abstract

The recent discovery of the role of receptor interacting protein 1 (RIP1) kinase in tumor necrosis factor (TNF)-mediated inflammation has led to its emergence as a highly promising target for the treatment of multiple inflammatory diseases. We screened RIP1 against GSK's DNA-encoded small-molecule libraries and identified a novel highly potent benzoxazepinone inhibitor series. We demonstrate that this template possesses complete monokinase selectivity for RIP1 plus unique species selectivity for primate versus nonprimate RIP1. We elucidate the conformation of RIP1 bound to this benzoxazepinone inhibitor driving its high kinase selectivity and design specific mutations in murine RIP1 to restore potency to levels similar to primate RIP1. This series differentiates itself from known RIP1 inhibitors in combining high potency and kinase selectivity with good pharmacokinetic profiles in rodents. The favorable developability profile of this benzoxazepinone template, as exemplified by compound 14 (GSK'481), makes it an excellent starting point for further optimization into a RIP1 clinical candidate.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1021/acs.jmedchem.5b01898

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 274

Metadata

Authors
Harris, P. A., King, B. W., Bandyopadhyay, D., Berger, S. B., Campobasso, N., Capriotti, C. A., Cox, J. A., Dare, L., Dong, X., Finger, J. N., Grady, L. C., Hoffman, S. J., Jeong, J. U., Kang, J., Kasparcova, V., Lakdawala, A. S., Lehr, R., McNulty, D. E., Nagilla, R., Ouellette, M. T., Pao, C. S., Rendina, A. R., Schaeffer, M. C., Summerfield, J. D., Swift, B. A., Totoritis, R. D., Ward, P., Zhang, A., Zhang, D., Marquis, R. W., Bertin, J., & Gough, P. J.
Venue
Journal of Medicinal Chemistry
Published
2016-02-23
Volume
59
Issue
5
Pages
2163-2178
ISSN
  • 0022-2623 (ISSN-L)
  • 1520-4804
OpenAlex
W2280294408
Cited by
274
References
5
FWCI
24.71
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: DNA-Encoded Library Screening Identifies Benzo[b][1,4]oxazepin-4-ones as Highly Potent and Monoselective Receptor Interacting Protein 1 Kinase Inhibitors. https://app.cochat.ai/papers/10.1021/acs.jmedchem.5b01898
The paper
Harris, P. A., King, B. W., Bandyopadhyay, D., Berger, S. B., Campobasso, N., Capriotti, C. A., Cox, J. A., Dare, L., Dong, X., Finger, J. N., Grady, L. C., Hoffman, S. J., Jeong, J. U., Kang, J., Kasparcova, V., Lakdawala, A. S., Lehr, R., McNulty, D. E., Nagilla, R., . . . Gough, P. J. (2016). DNA-Encoded Library Screening Identifies Benzo[b][1,4]oxazepin-4-ones as Highly Potent and Monoselective Receptor Interacting Protein 1 Kinase Inhibitors. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.5b01898

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.